Vaccine News and Research

Latest Vaccine News and Research

Booster dose elicits cross-reactive humoral immunity against SARS-CoV-2 Delta and Omicron variants

Researchers determine the cross-reactivity of the SARS-CoV-2 spike glycoprotein-induced antibodies before and after a third SARS-CoV-2 vaccine dose.

5 Jan 2022

Distrust in state power closely linked vaccine hesitancy

Distrust of the state in Turkey, religion and abortion resistance in the United States. Politics and culture are just as important in explaining vaccine hesitancy as health.

5 Jan 2022

Wistar announces initiation of Phase 2 clinical study of VK-2019 in patients with advanced head and neck cancer

The Wistar Institute announces the initiation of a Phase 2 clinical study of VK-2019 in patients with advanced Epstein-Barr Virus (EBV)-positive nasopharyngeal carcinoma (NPC) and lymphoma.

5 Jan 2022

Pre-departure test not needed for eligible fully vaccinated travelers

From 4am on Sunday 9 January, eligible fully vaccinated travellers and over 5s will be able to take a lateral flow test instead of a PCR on or before day 2 of their arrival in England. Lateral flow tests for travel can be booked from Friday 7 January and taken upon arrival, by the end of day 2.

5 Jan 2022

Study findings suggest spread of Omicron can be ascribed to immune evasiveness rather than an increase in transmissibility

Researchers investigate the household transmission of the Omicron VOC and increased immune evasiveness of both the Omicron and Delta variants

5 Jan 2022

Public attitudes to the COVID-19 pandemic during the emergence of the Omicron variant

Researchers from Swansea University have been investigating public attitudes to the pandemic.

5 Jan 2022

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

In a new study, researchers determined CD8+ and CD4+ T cell responses against the SARS-CoV-2 Omicron variant in 51 individuals vaccinated with the messenger ribonucleic acid (mRNA)-based Pfizer and adenovirus vector-based Johnson & Johnson vaccines.

5 Jan 2022

Comparison of the mutational profile of Omicron with other SARS-CoV-2 lineages

Researchers from nference labs in Massachusetts have been examining the origins of a particular mutation in the Omicron variant.

5 Jan 2022

COVID-19 mRNA vaccines offer protection against Omicron variant in pregnancy

A new study provides insights into the persistence of extra-neutralizing properties of mRNA vaccine-induced antibodies resulting in protection against the Omicron variant of SARS-CoV-2.

5 Jan 2022

Oral bacteria-based SARS-CoV-2 vaccine platform

In a new study, researchers engineered the bacterial strain, Salmonella, to express differently-sized antigens to serve as vaccine platforms.

5 Jan 2022

COVID-19 mitigation behaviors and vaccination status prediction via delay discounting and future orientation

New data imply that cognitive characteristics such as future-oriented thinking, evaluative processing, and behavioral control are linked to the likelihood of being fully vaccinated against COVID-19 and predict more consistent mitigation behavior implementation.

5 Jan 2022

Can the COVID-19 delta variant evade vaccine-induced immunity?

Can the COVID-19 delta variant evade vaccine-induced immunity? We spoke to Professor Brian J. Willett from the University of Glasgow to find out.

5 Jan 2022

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

A new preprint research paper posted to the medRxiv* server reports the induction of high neutralizing activity in these patients against the Omicron VOC with a booster dose.

5 Jan 2022

Scientists provide a structural framework for Omicron immune evasion and ACE2 receptor recognition

An interesting preprint research paper describes structural changes resulting from the multiple mutations found in the recent Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is the causative agent behind the coronavirus disease 2019 (COVID-19) pandemic. In addition, the research describes the consequent effects of these changes on Omicron’s infectivity and immune evasion capabilities.

5 Jan 2022

Transplant recipients benefit from a COVID-19 vaccine booster

A new preprint research paper posted to the medRxiv* server describes the reduction in humoral immunity in SOTR following vaccination, as well as the improvement with an additional dose of the vaccine.

4 Jan 2022

Time since COVID vaccination is a key driver of breakthrough Omicron infections

Published on the preprint medRxiv* server and awaiting peer review, the findings showed that the significant factor behind breakthrough Omicron infections is the timing from vaccination. The time between vaccination and breakthrough infections induced effective or cross-reactive neutralizing antibodies that neutralize Omicron after Alpha or Delta breakthrough infections.

4 Jan 2022

New study on NAbs against SARS-CoV-2 Omicron variant after vaccination or infection

A recent study suggests neutralizing antibody responses against variants of concern, including Omicron, differs significantly between vaccinated and naturally infected individuals. The research, posted to the medRxiv* preprint server, focused on vaccinated individuals who are pregnant — an understudied group in COVID-19 research.

4 Jan 2022

Lottery-based incentives are of limited value in increasing COVID-19 vaccine uptake

Will lottery prizes convince people to take the COVID-19 vaccine? It appears not, according to Boston University School of Medicine (BUSM) researchers.

4 Jan 2022

BNT162b2 provides low vaccine responders adequate anti-spike and neutralizing antibodies to prevent SARS-CoV-2

A new study, published on the medRxiv* preprint server, investigated the changes in SARS-CoV-2 antibody levels among HCWs after SARS-CoV-2 vaccination. The study also assessed whether low responders produced sufficient SARS-CoV-2 anti-spike and neutralizing antibodies.

4 Jan 2022

Study adds new evidence supporting the safety of COVID-19 vaccination during pregnancy

Pregnant people who contract COVID-19 have an increased risk of disease severity and death, yet only 31% of pregnant people in the United States had received vaccines as of September 2021.

4 Jan 2022

Vaccine News and Research

Latest Vaccine News and Research

Booster dose elicits cross-reactive humoral immunity against SARS-CoV-2 Delta and Omicron variants

Distrust in state power closely linked vaccine hesitancy

Wistar announces initiation of Phase 2 clinical study of VK-2019 in patients with advanced head and neck cancer

Pre-departure test not needed for eligible fully vaccinated travelers

Study findings suggest spread of Omicron can be ascribed to immune evasiveness rather than an increase in transmissibility

Public attitudes to the COVID-19 pandemic during the emergence of the Omicron variant

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

Comparison of the mutational profile of Omicron with other SARS-CoV-2 lineages

COVID-19 mRNA vaccines offer protection against Omicron variant in pregnancy

Oral bacteria-based SARS-CoV-2 vaccine platform

COVID-19 mitigation behaviors and vaccination status prediction via delay discounting and future orientation

Can the COVID-19 delta variant evade vaccine-induced immunity?

mRNA booster vaccine confers strong protection against SARS-CoV-2 Omicron in cancer patients

Scientists provide a structural framework for Omicron immune evasion and ACE2 receptor recognition

Transplant recipients benefit from a COVID-19 vaccine booster

Time since COVID vaccination is a key driver of breakthrough Omicron infections

New study on NAbs against SARS-CoV-2 Omicron variant after vaccination or infection

Lottery-based incentives are of limited value in increasing COVID-19 vaccine uptake

BNT162b2 provides low vaccine responders adequate anti-spike and neutralizing antibodies to prevent SARS-CoV-2

Study adds new evidence supporting the safety of COVID-19 vaccination during pregnancy

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in